Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.

Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1316-1323. doi: 10.1158/1055-9965.EPI-18-1262. Epub 2019 Jun 11.

PMID:
31186262
2.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
3.

Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1472-1479. doi: 10.1158/1055-9965.EPI-18-0582. Epub 2018 Aug 29.

PMID:
30158280
4.

Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Waterboer T, Pawlita M, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1186-1194. doi: 10.1158/1055-9965.EPI-18-0249. Epub 2018 Jul 23.

PMID:
30038049
5.

Social Relationships, Inflammation, and Cancer Survival.

Boen CE, Barrow DA, Bensen JT, Farnan L, Gerstel A, Hendrix LH, Yang YC.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):541-549. doi: 10.1158/1055-9965.EPI-17-0836. Epub 2018 Feb 23.

6.

Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer.

Diao K, Lobos EA, Yirmibesoglu E, Basak R, Hendrix LH, Barbosa B, Miller SM, Pearlstein KA, Goldin GH, Wang AZ, Chen RC.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e117-e124. doi: 10.1016/j.prro.2016.08.004. Epub 2016 Aug 12.

PMID:
28274402
7.

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Prostate. 2017 Jun;77(8):878-887. doi: 10.1002/pros.23342. Epub 2017 Mar 6.

8.

The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ET, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Cancer Causes Control. 2016 Dec;27(12):1475-1485. Epub 2016 Nov 9.

9.

Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.

Caster JM, Falchook AD, Hendrix LH, Chen RC.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):244-51. doi: 10.1016/j.ijrobp.2015.01.051. Epub 2015 Apr 1.

PMID:
25841621
10.

Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer.

Falchook AD, Hendrix LH, Chen RC.

J Oncol Pract. 2015 Mar;11(2):e239-46. doi: 10.1200/JOP.2014.001818. Epub 2015 Feb 10.

PMID:
25670199
11.

Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).

Chen RC, Carpenter WR, Kim M, Hendrix LH, Agans RP, Meyer AM, Hoffmeyer A, Reeve BB, Nielsen ME, Usinger DS, Strigo TS, Jackman AM, Anderson M, Godley PA.

J Comp Eff Res. 2015 Jan;4(1):3-9. doi: 10.2217/cer.14.67.

PMID:
25565065
12.

Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.

Jagsi R, Falchook AD, Hendrix LH, Curry H, Chen RC.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1001-9. doi: 10.1016/j.ijrobp.2014.09.032.

PMID:
25539365
13.

Cancer screening rates in individuals with different life expectancies.

Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC.

JAMA Intern Med. 2014 Oct;174(10):1558-65. doi: 10.1001/jamainternmed.2014.3895.

PMID:
25133746
14.

National study to determine the comfort levels of radiation therapists and medical dosimetrists to report errors.

Church JA, Adams RD, Hendrix LH, Holmes JA, Marks LB, Chen RC.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):e165-70. doi: 10.1016/j.prro.2012.12.001. Epub 2013 Jan 15.

PMID:
24674414
15.

Receipt of guideline-concordant treatment in elderly prostate cancer patients.

Chen RC, Carpenter WR, Hendrix LH, Bainbridge J, Wang AZ, Nielsen ME, Godley PA.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):332-8. doi: 10.1016/j.ijrobp.2013.11.004.

PMID:
24411605
16.

Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.

Falchook AD, Salloum RG, Hendrix LH, Chen RC.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):243-8. doi: 10.1016/j.ijrobp.2013.10.023. Epub 2013 Dec 7.

17.

Trends in the use of postprostatectomy therapies for patients with prostate cancer: a surveillance, epidemiology, and end results Medicare analysis.

Sheets NC, Hendrix LH, Allen IM, Chen RC.

Cancer. 2013 Sep 15;119(18):3295-301. doi: 10.1002/cncr.28222. Epub 2013 Jul 10.

18.

Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.

Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ, Chen RC.

Cancer. 2013 Jul 1;119(13):2486-93. doi: 10.1002/cncr.27975. Epub 2013 May 28.

19.

Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.

Kuykendal AR, Hendrix LH, Salloum RG, Godley PA, Chen RC.

Ann Oncol. 2013 May;24(5):1338-43. doi: 10.1093/annonc/mds618. Epub 2012 Dec 30.

20.

Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study.

Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, Godley PA, Chen RC.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):88-94. doi: 10.1016/j.ijrobp.2011.10.076. Epub 2012 Jan 31.

PMID:
22300560
21.

Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.

Holmes JA, Carpenter WR, Wu Y, Hendrix LH, Peacock S, Massing M, Schenck AP, Meyer AM, Diao K, Wheeler SB, Godley PA, Stitzenberg KB, Chen RC.

J Urol. 2012 Mar;187(3):883-8. doi: 10.1016/j.juro.2011.10.156. Epub 2012 Jan 15.

PMID:
22248516

Supplemental Content

Loading ...
Support Center